Zebrafish on drugs

In the November 21 Proceedings of the National Academy of Sciences, Peterson et al. describe a screen for chemicals that can be used to interfere with, and time, developmental events in zebrafish (Proc Natl Acad Sci USA 2000, 97:12965-12969). Zebrafish eggs were arrayed three to a well in 96-well plates, along with one of 1,100 synthetic small molecules. The developing embryos were screened once a day for three days for defects in the central nervous system, the cardiovascular system, pigmentat

Written byWilliam Wells
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

In the November 21 Proceedings of the National Academy of Sciences, Peterson et al. describe a screen for chemicals that can be used to interfere with, and time, developmental events in zebrafish (Proc Natl Acad Sci USA 2000, 97:12965-12969). Zebrafish eggs were arrayed three to a well in 96-well plates, along with one of 1,100 synthetic small molecules. The developing embryos were screened once a day for three days for defects in the central nervous system, the cardiovascular system, pigmentation, or ear development, with one person capable of screening approximately 400 compounds a day. Approximately 2% of the compounds were generally lethal or caused widespread necrosis, but approximately 1% of the compounds affected a specific aspect of one system under study. Peterson et al. demonstrated the utility of such probes by adding and washing away a particular chemical at different times, thus determining that a critical stage for ear development ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies